Evidence map›Paper›PMID 12875772›Full record

ArticleJournal of the American College of Cardiology2003

Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus.

Michaela Diamant, Hildo J Lamb, Ymte Groeneveld, Edwin L Endert, Jan W A Smit, Jeroen J Bax, Johannes A Romijn, Albert de Roos, Jasper K Radder

2 registry-linked trialsAbstract read
PubMed Publisher
In one paragraph

Article in Journal of the American College of Cardiology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 141 papers.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed
12.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01761318 phase4completedstarted 2013, after this paper: background citation

Magnetic Resonance Assessment of Victoza Efficacy in the Regression of Cardiovascular Dysfunction In Type 2 Diabetes Mellitus

Ran2013Enrolled50Registered outcomes48Posted comparisons0ConditionsCardiovascular Disease, Diabetes Mellitus Type 2, Diastolic Dysfunction, Fatty LiverArmsliraglutide, Liraglutide - Placebo
Open the trial in the graph
NCT00923962 nacompletednot on this mapstarted 2009, after this paper: background citation

Endothelial and Metabolic Effects of GLP-1 in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

TypeinterventionalSponsorUniversity Hospital, Gentofte, CopenhagenRan2009 to 2012Enrolled35ConditionsType 2 Diabetes MellitusArmsGlucagon like peptide-1, Adenosine
3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 370 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. NMR in biomedicine · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Human cardiac metabolism.Cell metabolism · 2024
    Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Michaela DiamantDepartment of Endocrinology, Leiden University Medical Center, Leiden, The Netherlands. m.diamant@vumc.nl
Hildo J Lamb
Ymte Groeneveld
Edwin L Endert
Jan W A Smit
Jeroen J Bax
Johannes A Romijn
Albert de Roos
Jasper K Radder
Leiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis study evaluated myocardial function in relation to high-energy phosphate (HEP) metabolism in asymptomatic patients with uncomplicated type 2 diabetes mellitus using magnetic resonance (MR) techniques.

backgroundMyocardial dysfunction may occur in patients with type 2 diabetes mellitus in the absence of coronary artery disease or left ventricular (LV) hypertrophy. The mechanisms underlying this diabetic cardiomyopathy are largely unknown, but may involve altered myocardial energy metabolism.

methodsWe assessed myocardial systolic and diastolic function and HEP metabolism in 12 asymptomatic normotensive male patients with recently diagnosed, well-controlled type 2 diabetes and 12 controls, using MR imaging and phosphorus-31-nuclear MR spectroscopy (31P-MRS) on a 1.5 T clinical scanner; 31P-MR spectra were quantified, and myocardial HEP metabolism was expressed as phosphocreatine to adenosine-triphosphate (PCr/ATP) ratio.

resultsNo differences were found in LV mass and systolic function between patients and controls. However, early (E) acceleration peak, deceleration peak, peak filling rate, and transmitral early-to-late diastolic peak flow (E/A) ratio, all indexes of diastolic function, were significantly decreased in patients compared with controls (p < 0.02). In addition, myocardial PCr/ATP in patients was significantly lower than in controls (1.47 vs. 1.88, p < 0.01). Inverse associations were found between myocardial PCr/ATP and E acceleration peak, E deceleration peak, and E peak filling rate (all, p < 0.05).

conclusionsThese results indicate that altered myocardial energy metabolism may contribute to LV diastolic functional changes in patients with recently diagnosed, well-controlled and uncomplicated type 2 diabetes.

Indexed as

DiastoleAdenosine TriphosphateAgedAnalysis of VarianceBlood GlucoseCardiomyopathiesCase-Control StudiesDiabetes Mellitus, Type 2Disease ProgressionEnergy MetabolismFatty Acids, NonesterifiedGlycated HemoglobinHemodynamicsHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyAdenosine TriphosphateBlood GlucoseFatty Acids, NonesterifiedGlycated HemoglobinPhosphocreatinePhosphorus Isotopes

Identifiers

PMID12875772
OpenAlexW1973860737

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.